1. Home
  2. IRIX vs ICU Comparison

IRIX vs ICU Comparison

Compare IRIX & ICU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IRIDEX Corporation

IRIX

IRIDEX Corporation

HOLD

Current Price

$0.66

Market Cap

15.0M

Sector

Health Care

ML Signal

HOLD

Logo SeaStar Medical Holding Corporation

ICU

SeaStar Medical Holding Corporation

HOLD

Current Price

$3.48

Market Cap

13.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IRIX
ICU
Founded
1989
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.0M
13.8M
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
IRIX
ICU
Price
$0.66
$3.48
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
67.4K
43.4K
Earning Date
05-12-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
51.85
N/A
EPS
N/A
N/A
Revenue
$41,593,000.00
$1,234,000.00
Revenue This Year
$3.07
$53.00
Revenue Next Year
$6.66
$50.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
814.07
52 Week Low
$0.61
$0.22
52 Week High
$1.65
$5.38

Technical Indicators

Market Signals
Indicator
IRIX
ICU
Relative Strength Index (RSI) 37.42 60.83
Support Level N/A $3.46
Resistance Level $0.98 $3.85
Average True Range (ATR) 0.03 0.20
MACD 0.01 0.08
Stochastic Oscillator 40.21 79.76

Price Performance

Historical Comparison
IRIX
ICU

About IRIX IRIDEX Corporation

IRIDEX Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.

About ICU SeaStar Medical Holding Corporation

SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.

Share on Social Networks: